ID | 32879 |
JaLCDOI | |
FullText URL | |
Author |
Umeda, Yuichi
Amano, Manabu
Suemaru, Katsuya
Yamaguchi, Takumi
Gomita, Yutaka
Araki, Hiroaki
|
Abstract | Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hyperglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexamethasone and streptozotocin. ACTH (100 μg/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.) and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats. The wet-dog shake responses induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 5-HT2A receptors under the condition of hyperactivity of the HPA axis. |
Keywords | hyperglycemia
ACTH
dexamethasone
streptozotocin
5-HT2A receptor
|
Amo Type | Original Article
|
Publication Title |
Acta Medica Okayama
|
Published Date | 2007-12
|
Volume | volume61
|
Issue | issue6
|
Publisher | Okayama University Medical School
|
Start Page | 311
|
End Page | 317
|
ISSN | 0386-300X
|
NCID | AA00508441
|
Content Type |
Journal Article
|
language |
English
|
File Version | publisher
|
Refereed |
True
|
PubMed ID | |
Web of Science KeyUT |